Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Unknown 1 Active not recruiting 1

Sponsor Class

OTHER 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13 Leukemia, Myeloid, Acute 12 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Head and Neck Neoplasms 6 Fallopian Tube Neoplasms 6 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leukemia 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Vulvar Neoplasms 3 Urinary Bladder Neoplasms 3 Recurrence 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Liver Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Fatigue 3 Depression 3 Central Nervous System Neoplasms 3 Carcinoma, Hepatocellular 3 Stress Disorders, Post-Traumatic 2 Small Cell Lung Carcinoma 2

Interventions

dehydroftorafur 1 Taxes 1 Platinum 1 Paclitaxel 1 Fluorouracil 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Anal Canal Carcinoma × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡